SEAGULL HEALTH
Your health,We care!
Its core features include anti-angiogenesis plus multi-target inhibition, broad-spectrum efficacy in later-line and combination therapies, and controllable administration and safety profile.
AuthenticGuaranteeFast DeliveryPrivacy Anlotinib is an oral multi-targeted tyrosine kinase inhibitor, primarily indicated for the targeted therapy of specific advanced cancers. To balance t···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 78
Anlotinib is an anti-tumor targeted drug. Its common adverse reactions include hypertension, bleeding risk, hand-foot syndrome, proteinuria, and gastr···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 78
The recommended dosage of anlotinib is 12 mg once daily, to be administered orally on an empty stomach (no food should be consumed 2 hours before and ···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 89
Anlotinib is an oral small-molecule multi-targeted tyrosine kinase inhibitor, primarily indicated for the treatment of patients with specific advanced···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 80
Anlotinib Hydrochloride Capsules is an antineoplastic agent belonging to the class of multi-targeted receptor tyrosine kinase inhibitors. It exerts it···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 79
The co-administration of anlotinib with other medications must be strictly conducted under the guidance of a physician. As an anti-tumor targeted drug···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 77
As a multi-targeted tyrosine kinase inhibitor indicated for the treatment of specific cancers, dosage adjustment for special populations must be stric···【Read More】
Update: 16 Jan,2026Source: Haiou HealthViews: 72
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
